1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MED28 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA KSR2 CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA DCAF16 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA PDE7A CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA CTCF CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA DLGAP3 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA ADRM1 CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA CCDC74A CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA NDUFS8 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA BAG3 CTRPv2 pan-cancer AAC -0.17 1e-05
Download CSV